20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T9925 | Ofatumumab | Others | |
Ofatumumab is a fully human monoclonal antibody to CD20 which appears to inhibit early-stage B lymphocyte activation | |||
T9915 | Eculizumab | Complement System | |
Eculizumab is a recombinant humanized monoclonal antibody against the complement protein C5 | |||
T9921 | Infliximab | TNF | |
Infliximab is a humanized antibody against tumor necrosis factor α TNF-α) that is used in the treatment of Crohn's disease and rheumatoid arthritis. | |||
T9927 | Panitumumab | EGFR | |
Panitumumab is a fully human IgG2 monoclonal antibody targeting the epidermal growth factor receptor EGFR). | |||
T9962 | Mepolizumab | SB 240563 | IL Receptor |
Mepolizumab (SB 240563) is a humanized monoclonal antibody neutralizing IL-5. Mepolizumab can be used in studies about severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis. | |||
T9922 | Matuzumab | EGFR | |
Matuzumab is a humanized monoclonal antibody used in cancer treatment. It has a high affinity for EGFR frequently associated with the growth of blood vessels in malignancy facilitating tumor growth and survival. | |||
T76769 | Indusatumab | Guanylate cyclase | |
Indusatumab (5F9 Monoclonal antibody) is an anti-human GUCY2C (Guanylate cyclase 2C) monoclonal antibody that can be used to synthesize antibody-drug conjugate. | |||
T77374 | Ontuxizumab | MORAb-004 | Others |
Ontuxizumab (MORAb-004) is a monoclonal antibody targeting endomelanic acid with anti-tumor effects.Ontuxizumab is a potent IgG1/κ anti-endothelin (TEM-1 or CD248) monoclonal antibody for the treatment of metastatic mela... | |||
T9913 | Ustekinumab | Interleukin | |
Ustekinumab is an anti-IL-12/IL-23 IgG1κ human monoclonal antibody. | |||
T77385 | Idactamab | INT-001 | |
Idactamab (INT-001) is a monoclonal antibody to the human amino acid transport protein ASCT2. | |||
T77480 | Bivatuzumab | BIWA 4 | Others |
Bivatuzumab (BIWA 4) is a humanized monoclonal antibody against CD44v6. | |||
T76891 | Oxelumab | Ro 49-89991,R 4930,huMAb OX 40L | Interleukin |
Oxelumab (R 4930) is a human monoclonal antibody for OX40L. Oxelumab could be used to study asthma. | |||
T77099 | Nimacimab | JNJ 2463,RYI-018 | Others |
Nimacimab is a recombinant humanized monoclonal antibody. It can improve diabetes and non-alcoholic steatohepatitis. | |||
T76744 | Enokizumab | MEDI-528 | IL Receptor |
Enokizumab (MEDI-528) is a monoclonal antibody against interleukin IL-9. Enokizumab can be used to study asthma. | |||
T9924 | Obinutuzumab | Obinutuzumab/afutuzumab | Others |
Obinutuzumab (Obinutuzumab/afutuzumab) GA101) is a glycoengineered Type II CD20 monoclonal antibody in development for non-Hodgkin lymphoma. | |||
T9901 | Adalimumab | TNF | |
Adalimumab (anti-TNF-alpha) is the first fully human recombinant IgG1 monoclonal antibody that specifically targets human TNF-alpha. | |||
T9903 | Avelumab | PD-1/PD-L1 | |
Avelumab is a fully human IgG1 anti-PD-L1 monoclonal antibody. Avelumab shows potential antibody-dependent cell-mediated cytotoxicity. | |||
T77399 | Crizanlizumab | ADAKVEO,SEG-101 | Others |
Crizanlizumab (Adakveo) is a humanized monoclonal antibody against P-selectin for the prevention of pain crises in sickle cell disease. | |||
T76975 | Tomaralimab | OPN-305 | TLR |
Tomaralimab (OPN-305) is a humanized IgG4 monoclonal antibody targeting TLR2. Tomarlimab is used to study myelodysplastic syndromes (MDS). | |||
T9904 | Bevacizumab | VEGFR | |
Bevacizumab, a humanized monoclonal antibody, specifically and with high affinity binds to all isoforms of VEGF-A. |